Alvogen Aims To Be First On EU Pazopanib

Rival To Novartis’ Votrient Filed For Several European Markets

 
• By Dave Wallace
  
Starting_Block
Alvogen is aiming to be first off the blocks with generic pazopanib in Europe • Source: Shutterstock

More from Generics

More from Products